| No headlines available for GLSAX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 5.96M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 13.02% | | 5y Avg Return: | 1.87% | | Rank in Category (ytd): | 127 | | % Rank in Category (ytd): | 76.97% | | Beta (3y): | 0.76 | | Morningstar Risk Rating: | Average |
|
| The investment seeks long-term capital appreciation. The fund invests at least 80% of net assets in equity securities issued by U.S. and foreign companies with business operations in or related to health sciences. It invests 25% or more of assets in at least one of the following industry groups: healthcare; pharmaceuticals; biotechnology; medical supplies; medical services and medical devices. The fund may invest in health sciences companies of any size, including established large-cap companies that are expected to grow with the market and small-cap and mid-cap companies that may offer strong prospects for future growth. It is nondiversified. | | | Fund Profile |
|
Help
0.07 (0.74%) 
Summary
Add GLSAX to Portfolio 
Download Data
